The PCSK9 inhibitor market is emerging as one of the most promising segments within the global cardiovascular therapeutics industry. With cardiovascular diseases continuing to represent a leading cause of death worldwide, healthcare providers and pharmaceutical companies are focusing on innovative treatment approaches to effectively manage cholesterol levels and prevent life-threatening...